NGM Biopharmaceuticals
Phase 2Our broad, diverse pipeline of novel, first-in-class medicines spans multiple therapeutic areas and diseases. Every program focuses on a large market indication with high unmet needs and a common goal: delivering outsized impact for patients.
Founded
2008
Focus
BiologicsSmall Molecules
About
Our broad, diverse pipeline of novel, first-in-class medicines spans multiple therapeutic areas and diseases. Every program focuses on a large market indication with high unmet needs and a common goal: delivering outsized impact for patients.
Funding History
6Total raised: $631M
PIPE$250MRocheJul 15, 2020
IPO$106MUndisclosedApr 4, 2019
Series D$106MThe Column GroupJun 15, 2017
Series C$94MThe Column GroupJun 15, 2014
Company Info
TypePrivate
Founded2008
LocationSouth San Francisco, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile